Safety Study of Salmeterol in Asthma in Adults

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)


The trial reported by Stempel et al. (May 12 issue),1 which is one of five large trials conducted per requirements from the Food and Drug Administration (FDA),2 shows the safety of an inhaled long-acting beta-agonist (LABA) in patients with asthma. Concerns regarding the trial design were raised previously...
Original languageEnglish
Pages (from-to)1096-1097
Number of pages2
JournalNew England Journal of Medicine
Issue number11
Publication statusPublished - 15 Sept 2016


  • Asthma
  • Salmeterol
  • long-acting beta-agonist (LABA)


Dive into the research topics of 'Safety Study of Salmeterol in Asthma in Adults'. Together they form a unique fingerprint.

Cite this